ABSTRACT
Peters' anomaly (PA) is a congenital defect of the anterior chamber of the eye. We identified a family in which an apparently balanced chromosomal translocation t(1;7) (q41;p21) was associated with PA. Based on this observation, detailed molecular characterizations of the breakpoint regions and candidate genes were carried out. A candidate gene from each breakpoint was identified: on chromosome 7, histone deacetylase 9 (HDAC9), disrupted by the translocation breakpoint, and on chromosome 1, transforming growth factor-beta2 (TGFbeta2) located 500 kb proximal to the breakpoint. An additional lysophospholipase-like 1 gene (LYPLAL1), localized approximately 200 kb distal to the chromosome 1 breakpoint, was also identified and characterized. Although only the HDAC9 gene is disrupted by the breakpoint, we consider that TGFbeta2 represents the main candidate gene in this family, which is elicited in mice by the Tgfbeta2-null status and by the TGFbeta2-induced cataractus changes in animal models. As an alternative scenario, which is supported by the ability of class II HDACs to mediate extracellular TGF-beta stimuli to core histone deacetylation in promoter-adjacent regions, we propose the hypothesis of digenic inheritance. Inappropriate or inadequate TGFbeta2 expression, together with deficient mediation of these signals at the transcription level, due to an altered HDAC9 isoforms ratio, may also lead to the observed ocular phenotype.
Subject(s)
Cataract/genetics , Histone Deacetylases/genetics , Repressor Proteins/genetics , Transforming Growth Factor beta/genetics , Translocation, Genetic , Base Sequence , Chromosome Mapping , Chromosomes, Human, Pair 1 , Chromosomes, Human, Pair 7 , Female , Histone Deacetylases/metabolism , Humans , In Situ Hybridization, Fluorescence , Male , Middle Aged , Molecular Sequence Data , Pedigree , Repressor Proteins/metabolism , Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta2ABSTRACT
The Turner syndrome (TS) has been described in association with different sex chromosome aberrations. Although most TS patients show no evidence of Y chromosome sequences, according to different authors some TS patients may have Y chromosome material present in a few cells that are not detected by standard cytogenetic analysis. The importance of identification of this low level Y mosaicism is of clinical relevance due to the patient's increased risk of developing gonadoblastoma. In the present study, standard chromosome analysis performed on peripheral blood lymphocytes from 22 TS patients showed 12 patients with 45,X karyotype, 7 patients were mosaics with or without structural abnormalities in one X chromosome and, the remaining three patients had the following karyotypes: 46,X,i(X)(q10); 46,X,+mar/47,X,idic(Y),+mar and 45,X/46,X,+r. Molecular studies were performed on genomic DNA extracted from peripheral blood lymphocytes and mouth epithelial cells, which derive from two different embryonic germ layers, mesoderm and ectoderm, respectively. The screening for low level Y mosaicism was carried out by simplex PCR and by nested PCR of the following Y specific loci: SRY (sex determining region Y), TSPY (testis specific protein Y encoded), DYZ3 (centromeric locus) and DAZ1 (deleted in azoospermia). In two TS patients a set of STSs of the Y long and short arms were used to characterize the idic(Y) and the ring chromosomes. The high sensitivity of the nested PCR (1 male cell/125,000 female cells) allowed for exclusion of the presence of low level Y mosaicism in 20 out of 22 TS patients. In the patient with the idic(Y), PCR analysis was positive for all Y loci tested excluding the heterochromatic region. This result identified the breakpoint between sY158 and sY159 on the long arm and, by fluorescence in situ hybridization (FISH) it was confirmed that the euchromatic part of the long arm, centromere and short arm of the Y chromosome were duplicated. The characterization of the ring chromosome, detected in one of the TS patients, was only possible to analyse by FISH and PCR. In this ring, derived from the Y chromosome, a deletion was identified including the pseudoautosomal region 1 (PARY1) and Y intervals 6 and 7. However, the ring Y was positive for SRY, RPS4Y, AMGY, TSPY loci on the short arm, DYZ3 (centromere) and, sY85, DFFRY, GY6, sY87, sY113, sY119, sY122, sY126 and RBMY1 on the long arm. This study excluded the presence of low level Y mosaicism in two tissues collected from 20 TS patients. FISH and molecular analysis allowed us to characterize, in 2 out of 22 patients, one idic(Y) and one ring chromosome. The nature of the latter had not been completely identified by standard cytogenetics. The potential increased risk of gonadoblastoma in TS patients carrying Y chromosome sequences justifies the application of FISH and PCR for the characterization of marker chromosomes and the application of nested PCR for the detection of low level Y mosaicisms when Y chromosome material is not detected by standard cytogenetic analysis in patients with a 45,X karyotype and/or with virilization.